Professional Documents
Culture Documents
Hematologicalemergencies 2 190101164652
Hematologicalemergencies 2 190101164652
EMERGENCIES-2
Ajay Kumar Yadav
PGY3,Medicine
IOM-TUTH, Kathmandu
LAYOUT
• Hyperleucocytosis and leucostasis
• Neutropenic enterocolitis
HYPERLEUCOCYTOSIS
AND
LEUCOSTASIS
INTRODUCTION
• Hyperleukocytosis : Refers to lab abnormality that has been variably defined as a total leukemia
blood cell count greater than 50,000/microL or 100,000/microL.
Medical emergency
Characterized by an extremely elevated blast cell count and symptoms of decreased tissue
perfusion.
Cont..
• Leucostasis is a Pathologic diagnosis white cell plugs are seen in the microvasculature.
• Clinically diagnosed empirically when a patient with leukemia and hyperleukocytosis presents
with respiratory or neurological distress.
• Prompt t/t is indicated since, if left untreated, the one-week mortality rate is approx. 20 to 40 pc.
• ALL:
• The incidence appears to be highest in infants, patients between the ages of 10 and 20 years,
males, and those with a T cell phenotype
• Symptoms of leukostasis are rarely seen.
• TLS and DIC are more common complications related to the elevated WBC count.
• CLL
• Symptoms of leukostasis are rare unless the WBC count exceeds 400 x 109/L.
• CML
• Pts. with CML typically present with leukocytosis and a median WBC count of approx. 100 x
109/L
• Symptoms of leukostasis are very uncommon in chronic phase but can be seen occ. in
patients with myeloid blast crisis and very elevated blast counts.
PATHOPHYSIOLOGY OF LEUKOSTASIS
• There are two main theories, which are not mutually exclusive:
Large population of leukemic blasts (less deformable than mature leukocytes) Increases blood
viscosity Plug microcirculation impede blood flow (leukostasis).
Worsened by RBC transfusions or the use of diuretics, both of which can increase whole
blood viscosity.
Local hypoxemia may be exacerbated by the high metabolic activity of the dividing blasts and the
associated production of various cytokines Endothelial damage.
• Primitive myeloid leukemic cell are capable of invading through the endothelium and causing
hemorrhage.
• Neurological involvement
• Visual changes, headache, dizziness, tinnitus, gait instability, confusion, somnolence, and,
occasionally, coma.
• Increased risk of intracranial hemorrhage that persists for at least a week after the reduction
of white cell count, perhaps from a reperfusion injury as areas of the brain that were
ischemic from leukostasis regain blood flow.
Cont..
• Approx. 80 pc. of pts. with leukostasis are febrile, which may be due to inflammation associated with
leukostasis or concurrent infection.
• Priapism,
• Bowel infarction
LABORATORY ABNORMALITIES
• Spontaneous TLS is present in up to 10 pc. of pts. with leucostasis : Uric acid, potassium,
phosphate, calcium and creatinine.
TREATMENT
• For pts with symptomatic or asymptomatic hyperleukocytosis
• Initial t/t with induction chemotherapy rather than hydroxyurea or leukapheresis.
• Accompanied by TLS prophylaxis with aggressive hydration and allopurinol.
• For pts without symptoms of leukostasis who must have induction chemotherapy delayed
• Cytoreduction with hydroxyurea rather than leukapheresis.
• Cytoreduction with hydroxyurea can ppt. or exacerbate hyperuricemia and/or TLS IV
hydration and TLS prophylaxis.
• For pts with symptoms of leukostasis who must have induction chemotherapy delayed
• Initial cytoreduction with leukapheresis in combination with hydroxyurea to lower or stabilize
the WBC count.
Cont..
• Treatment of the leukemia can result in pulmonary hemorrhage from lysis of blasts in the lung,
called leukemic cell lysis pneumopathy.
• When APML is treated with differentiating agents like tretinoin and arsenic trioxide
• Cerebral or pulmonary leukostasis may occur as tumor cells differentiate into mature
neutrophils(Differentiation syndrome).
• This complication can be largely avoided by using cytotoxic chemotherapy or arsenic together
with the differentiating agents.
MALLIGNANTN SPINAL CORD
COMPRESSION(MSCC)
INTRODUCTION
• MSCC is defined as compression of the spinal cord and/or cauda equina by an extradural tumor
mass.
• The minimum radiologic evidence for cord compression is indentation of the theca at the level of
clinical features.
• Lung, breast, and prostate cancer are the most frequent offenders.
• Lymphomas, melanoma, renal cell cancer, and genitourinary cancers also cause cord
compression.
• The thoracic spine is the most common site (70%), followed by the lumbosacral spine (20%) and
the cervical spine (10%).
• Involvement of multiple sites is most frequent in patients with breast and prostate carcinoma.
• Direct extension of a paravertebral lesion through the intervertebral foramen : Lymphoma,
myeloma, or pediatric neoplasm.
• Intramedullary metastases can be seen in lung cancer, breast cancer, renal cancer, melanoma, and
lymphoma.
PATHOPHYSIOLOGY
• Obstruction of the epidural venous plexus leads to edema.
• Local production of inflammatory cytokines enhances blood flow and edema formation.
• Production of vascular endothelial growth factor is associated with spinal cord hypoxia.
CLINICAL FEATURES
• Localized back pain and tenderness : MC presentation
• Involvement of vertebrae by tumor.
• Pain is usually present for days or months before other neurologic findings appear.
• Exacerbated by movement and by coughing or sneezing.
• Loss of bowel or bladder control may be the presenting symptom but usually occurs late in the
course.
• Occasionally pts present with ataxia of gait without motor and sensory involvement due to
involvement of the spinocerebellar tract.
PHYSICAL EXAMINATION
• Pain induced by SLRT, neck flexion, or vertebral percussion may help to determine the
level of cord compression.
• Motor examination
• Spastic weakness, spasticity
• Extensor plantar reflex and brisk DTR.
• Present with decreased anal tonus, decreased perineal sensation, and distended bladder.
• The absence of the anal wink reflex or the bulbocavernosus reflex confirms cord involvement.
• Diminished sensation over the buttocks, posterior-superior thighs, and perineal area in a saddle
distribution
• The majority of cauda equine tumors are primary tumors of glial or nerve sheath origin; metastases are
very rare.
IMAGING
• IOC
• Full-length image of the cord by Contrast MRI
• Myelography : Reserved for pts who have poor MRIs or who cannot undergo MRI promptly.
• CT Erosion of the pedicles (the “winking owl” sign) is the earliest radiologic finding.
• Up to 75% of pts treated when still ambulatory remain ambulatory, but only 10% of patients with
paraplegia recover walking capacity.
• INDICATIONS FOR SURGICAL INTERVENTION
• Unknown etiology,
• Laminectomy
• Posteriorly localized epidural deposits in the absence of vertebral body disease.
• Resection of the anterior vertebral body along with the tumor, followed by spinal stabilization
• Anterior or anterolateral epidural abscess.
• A RCT showed that pts who underwent surgery followed by radiotherapy (within 14 days)
retained the ability to walk significantly longer than those treated with radiotherapy alone.
• Chemotherapy may have a role in pts with chemosensitive tumors who have had prior
radiotherapy to the same region and who are not candidates for surgery.
• Patients with metastatic vertebral tumors may benefit from percutaneous vertebroplasty or
kyphoplasty, the injection of acrylic cement into a collapsed vertebra to stabilize the fracture.
• Pain palliation is common.
• Cement leakage seen in 10% of pts.
APPROACH TO PTS WITH MSCC
Cont..
HUMAN ANTIBODY INFUSION REACTIONS
• Seen with initial infusion of human or humanized antibodies (e.g., rituximab,
gemtuzumab, trastuzumab, alemtuzumab, panitumumab, brentuximab vedotin)
• A/w fever, chills, nausea, asthenia, and headache in up to half of treated pts.
• Pathogenesis
• Activation of immune effector processes (cells and complement) release of inflammatory
cytokines, s/a TNF-α, INF-gamma, IL-6, and IL-10 (Cytokine Release Syndrome[CRS]).
• Treatment
• Diphenhydramine, hydrocortisone, and acetaminophen can often prevent or suppress the
infusion-related symptoms.
• If they occur, the infusion is stopped and restarted at half the initial infusion rate after the
symptoms have abated.
• Severe CRS may require intensive support for ARDS and resistant hypotension.
NEUTROPENIC ENTEROCOLITIS
INTRODUCTION
• Neutropenic enterocolitis (Typhlitis) is the inflammation and necrosis of the cecum and
surrounding tissues that may complicate the treatment of acute leukemia.
• Nevertheless, it may involve any segment of the GIT including small intestine, appendix, and
colon.
• Clinical presentation
• Right lower quadrant abdominal pain, often with rebound tenderness and a tense, distended
abdomen, in a setting of fever and neutropenia.
• Watery diarrhea (often containing sloughed mucosa)along with bleed.
• Bacteremia
DIAGNOSIS
• CT SCAN
• Marked bowel wall thickening, particularly in the cecum,
• Bowel wall edema,
• Mesenteric stranding, and
• Ascites
• Patients with bowel wall thickness >10 mm on USG have higher mortality rates.
• Pneumatosis intestinalis is a more specific finding, seen only in those with neutropenic
enterocolitis and ischemia.
• The combined involvement of the small and large bowel suggests a diagnosis of neutropenic
enterocolitis
TREATMENT
• Rapid institution of broad-spectrum antibiotics, bowel rest, and nasogastric suction.
• Surgical intervention
• UpToDate 2018
THANK YOU